Abstract:Objective: To explore the expression of Shh signaling pathway factors in Gastrointestinal stromal tumor (GIST) tissues and their associations with clinical pathological factors. Methods: 129 GIST patient cases that underwent surgery treatment at the first affiliated hospital of Anhui Medical University from January 2001 to December 2008 and with complete records were collected. The expression of Shh signaling pathway proteins Shh, Ptch, Smo and Gli-1 was assayed using immunohistochemistry methods, and the relation between these protein expression and the tumor site, diameter, mitotic figures, NIH risk classification, reoccurrence and prognosis of GIST was analyzed. Results: The expression rate of these four proteins, Shh, Ptch, Smo and Gli-1, in GIST tissues was 90.5%, 83.3%, 85.7%, and 85.7% respectively; The expression level of Ptch was positively associated with that of Smo, but not with Gli-1; the expression level of Smo was positively associated with that of Gli-1; the expression level of Shh, Ptch, Smo or Gli-1 was not associated with patients' gender or age, while it was associated with tumor size, mitotic figures, and risk classification. The positive expression rate of Shh, Ptch, Smo and Gli-1 in GISTs with high and median risk according to NIH classification was substantially higher than those with extremely low and low risk, and the difference was significant. The positive expression rate of Shh, Ptch, Smo and Gli-1 was significantly higher in recurrent GIST than non-recurrent GIST. The 1-, 3-, and 5-year survival rates of patients with positive expression of Shh, Ptch, Smo and Gli-1 were markedly lower than those with negative expression. The positive expression of Gli-1 was an independent risk factor of patients' prognosis. Conclusion: The Shh signaling pathway was present and activated in the GIST tissues. The expression of critical proteins in the Shh signaling pathway was correlated, and they may participate in the origination and development of GIST through ligand-dependent activation. The expression of proteins in the Shh signaling pathway was associated with the reoccurrence and prognosis of GIST, particularly, the expression of Gli-1 protein may be used as an important indicator for predicting reoccurrence.

[Expression of SV40Tag, Rb and IRS-1 in Glioma Detected by Tissue Microarray and Their Relation with Tumorigenesis and Progression of Gliomas].

Expression of SV40 Tag and Formation Tag-p53 and Tag-Rb Complexes in Chinese Brain Tumors

Analysis of Hsa-Mir-30a-5p Expression in Human Gliomas

Expression of SV40 large tumor antigen in human brain tumors

Expression of the Simian Virus 40 Large Tumor Antigen (tag) and Formation of Tag-p53 and Tag-pRb Complexes in Human Brain Tumors

Formation of Specific Complex of SV40 Large Tumor Antigen and P53 in Human Brain Tumors

Expression Of Shh Signaling Pathway Factors In Gastrointestinal Stromal Tumor Tissues And Their Associations With Clinical Pathological Factors

The expression of insulin-like growth factor-I receptor in human glioma and its significance

The Expression of CD44s and Mib-1 in Astrocytomas and Their Clinical Significance

Expression and Significance of IE1-72 Protein of Human Cytomegalovirus in Gliomas

Expression and significance of TβRⅢ in tissue of human glioma

[Study on Expression of ING1, Human Telomerase Reverse Transcriptase and Telomerase-Associated Protein 1 Genes in Human Gliomas].

Correlation Analysis Between the Expression of P21WAF1/CIP1, P16 Proteins and Human Glioma

Expression and relationship of RGS16 and p53 in human glioma

Expressions of SLC5A8 and TMS1/ASC in Primary Glioma

miR-19a and miR-19b Overexpression in Gliomas

Expression of HMGB1 gene and its clinical significance in human glioma: a Meta-analysis

Expression and clinical significance of serum IGF-I and TSGF in human glioma

Survivin Expression and Its Relation with Proliferation, Apoptosis, and Angiogenesis in Brain Gliomas

Expression and significance of pp65 protein of human cytomegalovirus in gliomas

SRSF1 induces glioma progression and has a potential diagnostic application in grading primary glioma